Back to stocks
SLS

SLS

SELLAS Life Sciences Group, Inc.

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
18
Partial Q3 2026
Total 13F value
$7.7M
Filed positions so far
New positions
2
This quarter
Sold positions
2
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Everhart Financial Group, Inc.

$3M240.2K0.18%-16.6%

Vontobel Holding Ltd.

$1.8M147.7K0.01%+0.7%

Fulcrum Wealth Advisors, Llc

$1.1M85.5K0.73%+16.6%

Elco Management Co., Llc

$301K24.4K0.14%+71.8%

Independent Financial Group, Llc

$295K24.0K0.01%+3.2%

Martin Capital Advisors, Llp

$284K23.1K0.15%Unchanged

Ridgewood Investments Llc

$277K22.5K0.10%Unchanged

Financial Designs Corp

$236K19.2K0.12%-17.8%

Concurrent Investment Advisors, Llc

$220K17.9K0.00%New Position

First Financial Bank - Trust Division

$123K10.0K0.01%Unchanged

Farther Finance Advisors, Llc

$30K2.4K0.00%+2.0%

Gamma Investing Llc

$27K2.2K0.00%+293.2%

Ifp Advisors, Inc

$11K9250.00%Unchanged

Corecap Advisors, Llc

$8K6900.00%Unchanged

Armstrong Advisory Group, Inc

$5K3800.00%Unchanged

Fortitude Family Office, Llc

$3K2590.00%Unchanged

Versant Capital Management, Inc

$2K1310.00%New Position

Massmutual Private Wealth & Trust, Fsb

$283230.00%-4.2%

Explore